Aguirre Jarrad Mattieu
Chief Medical Officer
Aguirre Jarrad Mattieu has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Oct 13, 2026.
On the most recent filing, Aguirre Jarrad Mattieu is listed as Chief Medical Officer at Lyell Immunopharma, Inc. Inside the rolling window, Aguirre Jarrad Mattieu reported no open-market purchases and 1 open-market sale totaling $4K in LYEL.
Companies traded
Other insiders at LYEL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Aguirre Jarrad Mattieu made?
Aguirre Jarrad Mattieu has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Aguirre Jarrad Mattieu trade?
Aguirre Jarrad Mattieu has filed SEC Form 4 disclosures for 1 company, including LYEL.
When was Aguirre Jarrad Mattieu's most recent SEC Form 4 filing?
Aguirre Jarrad Mattieu's most recent SEC Form 4 filing on Tracefour is dated Oct 13, 2026.
What is Aguirre Jarrad Mattieu's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Aguirre Jarrad Mattieu is listed as Chief Medical Officer.
What is Aguirre Jarrad Mattieu's total buy and sell value in the current window?
Inside the rolling retention window, Aguirre Jarrad Mattieu bought $0 and sold $4K based on SEC Form 4 filings.
What was Aguirre Jarrad Mattieu's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 422 LYEL shares on 2026-10-12, worth $4K, per SEC Form 4 filings.